Next-generation weight loss pills are expected to hit the market next year, and drugmakers are working on medications with ...

PFE's oncology gains and obesity re-entry contrast with NVO's GLP-1 pressures in this in-depth comparison of two healthcare ...

Partnership combines world-renowned pharmaceutical leadership with an agile health-tech platform to make the ...

Viking Therapeutics › Novo Nordisk (NYSE: NVO), a Denmark-based drugmaker, is currently a leader in the rapidly growing ...

Novo Nordisk NVO announced that it has submitted a regulatory filing seeking label expansion for a higher dose of its ...

Novo Nordisk A/S (NYSE:NVO) is one of the Best Very Cheap Stocks to Invest In. On November 24, Richard Vosser from J.P.

Novo Nordisk is chopping prices again for its popular obesity treatment Wegovy, but doctors say the expense will remain ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression of Alzheimer’s disease in closely watched trials, Novo Nordisk said.

Explore the deepening job market crisis in the US as layoffs surge in 2025, driven by tariffs, rising costs, and increased AI ...

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

The singer and actress has lost more than 60Ibs through a combination of regular exercise, dietary tweaks and low doses of ...

European equities eked out a modest gain on Thursday, with the pan-European Stoxx 600 reversing early losses to finish 0.12% ...